65 agent-based-modelling Fellowship positions at University of British Columbia in Canada
Sort by
Refine Your Search
-
, policy, energy conversion, new business models, techno-economic and life cycle analyses, machine learning, optimization, AI, intelligent networks, among others. The PDF will join a project in collaboration
-
functional genomics, CRISPR-based screening, or single-cell technologies. Hands-on experience with next-generation sequencing library prep and tissue culture models. Demonstrated ability to conduct independent
-
understood, modeled, and ultimately reversed or rebuilt using bioengineering and synthetic biology approaches. The successful candidate will: Investigate mechanisms of T-cell development, aging, and thymic
-
-cell compartment, develops and deteriorates with age, and how these processes can be understood, modeled, and ultimately reversed or rebuilt using bioengineering and synthetic biology approaches
-
members on combinatorial CRISPR screen strategies for target credentialing in cancer models Computational analysis of screen data Design and execution of combinatorial target validation experiments in PDXO
-
ambitious research projects connected to love-based ethics. These fellows will join the institute from July 2026 through June 2028. In addition to pursuing independent research on love-based ethics
-
be accepted until 11:59 PM on the Posting End Date. Job End Date Jun 30, 2027 The expected pay for this position is $60,000/year with potential for negotiation based on the qualifications and
-
. Prior experience in at least one of the following is a requirement: physiologically based pharmacokinetic (PBPK) modeling, computational oncology/biology, kinetic modeling, advanced image processing
-
: physiologically based pharmacokinetic (PBPK) modeling, computational oncology/biology, kinetic modeling, advanced image processing. The candidate should be highly motivated with a strong interest and commitment
-
healing. The Granville research program spans basic molecular biology and biochemistry through to target validation, proof-of-concept in animal and human models, and collaborations with clinicians and